@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix proteinModification: . @prefix psimod: . @prefix mesh: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:7997; a Protein: . sub:_2 belv:variantOf hgnc:12440; a proteinModification:, psimod:00696 . sub:_3 occursIn: mesh:D004848, mesh:D008168, species:9606; rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(HGNC:NRG1) -> p(HGNC:TYK2,pmod(P))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "1.4" . sub:_4 prov:value "Treatment of cells with NGR-1 showed a 7 and 14 fold increase in JAK3 and TYK2 phosphorylation after 10 mins and rapidly decreased to their basal level, but when treated with 2C4, a specific antibody of HER-2 there was a total abrogation in this phosphorylation, indicating that HER2 receptor is required for NGR-1 induced activation of JAK3 and TYK2 phosphorylation."; prov:wasQuotedFrom pubmed:12204892 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12204892; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:05.369+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }